Elbadawi, A., Mahtta, D., Elgendy, I. Y., Saad, M., Krittanawong, C., Hira, R. S., … Jneid, H. (2020). Trends and Outcomes of Fibrinolytic Therapy for STEMI: Insights and Reflections in the COVID-19 Era. JACC Cardiovasc Interv, 13(19), 2312–2314. https://doi.org/10.1016/j.jcin.2020.07.004

Elbadawi, Ayman, Dhruv Mahtta, Islam Y. Elgendy, Marwan Saad, Chayakrit Krittanawong, Ravi S. Hira, Mohamed Omer, et al. “Trends and Outcomes of Fibrinolytic Therapy for STEMI: Insights and Reflections in the COVID-19 Era.” JACC Cardiovasc Interv 13, no. 19 (October 12, 2020): 2312–14. https://doi.org/10.1016/j.jcin.2020.07.004.

Elbadawi A, Mahtta D, Elgendy IY, Saad M, Krittanawong C, Hira RS, et al. Trends and Outcomes of Fibrinolytic Therapy for STEMI: Insights and Reflections in the COVID-19 Era. JACC Cardiovasc Interv. 2020 Oct 12;13(19):2312–4.

Elbadawi, Ayman, et al. “Trends and Outcomes of Fibrinolytic Therapy for STEMI: Insights and Reflections in the COVID-19 Era.” JACC Cardiovasc Interv, vol. 13, no. 19, Oct. 2020, pp. 2312–14. Pubmed, doi:10.1016/j.jcin.2020.07.004.

Elbadawi A, Mahtta D, Elgendy IY, Saad M, Krittanawong C, Hira RS, Omer M, Ogunbayo GO, Garratt K, Rao SV, Jneid H. Trends and Outcomes of Fibrinolytic Therapy for STEMI: Insights and Reflections in the COVID-19 Era. JACC Cardiovasc Interv. 2020 Oct 12;13(19):2312–2314.